259 related articles for article (PubMed ID: 11144906)
21. An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ.
Milord RA; Lecksell K; Epstein JI
Hum Pathol; 2001 Sep; 32(9):997-1002. PubMed ID: 11567231
[TBL] [Abstract][Full Text] [Related]
22. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
23. [Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions].
Helpap B; Köllermann J
Pathologe; 2000 May; 21(3):211-7. PubMed ID: 10900613
[TBL] [Abstract][Full Text] [Related]
24. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system.
Miyamoto H; Miller JS; Fajardo DA; Lee TK; Netto GJ; Epstein JI
Pathol Int; 2010 Jan; 60(1):1-8. PubMed ID: 20055945
[TBL] [Abstract][Full Text] [Related]
25. [Detection of precancerous lesions of the bladder by contact-micro-cystoscopy].
Nakao M; Nakagawa S; Toyoda K; Nukui M; Takada H; Ebisui K; Sugimoto K; Watanabe H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1623-8. PubMed ID: 2730057
[TBL] [Abstract][Full Text] [Related]
26. Pathology of superficial bladder cancer with emphasis on carcinoma in situ.
Weinstein RS; Coon JS; Schwartz D; Miller AW; Pauli BU
Urology; 1985 Oct; 26(4 Suppl):2-10. PubMed ID: 3901485
[TBL] [Abstract][Full Text] [Related]
27. Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasia.
Amin MB; Young RH
Semin Diagn Pathol; 1997 May; 14(2):84-97. PubMed ID: 9179970
[TBL] [Abstract][Full Text] [Related]
28. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
Kalantari MR; Ahmadnia H
Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
[TBL] [Abstract][Full Text] [Related]
29. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
[TBL] [Abstract][Full Text] [Related]
30. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
van der Kwast TH
Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
[TBL] [Abstract][Full Text] [Related]
31. Review. Non-papillary urothelial lesions of the urinary bladder: morphological classification and immunohistochemical markers.
Petraki CD; Sfikas CP
In Vivo; 2008; 22(4):493-501. PubMed ID: 18712178
[TBL] [Abstract][Full Text] [Related]
32. [Histologic and cytologic aspects of urothelial atypia (dysplasia)].
Helpap B; Bödeker J; Pfitzenmaier N
Pathologe; 1985 Nov; 6(6):292-7. PubMed ID: 4088975
[No Abstract] [Full Text] [Related]
33. Prognostic significance of atypical papillary urothelial hyperplasia.
Swierczynski SL; Epstein JI
Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
35. Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder.
Kong QY; Liu J; Chen XY; Wang XW; Sun Y; Li H
Oncol Rep; 2003; 10(1):51-5. PubMed ID: 12469144
[TBL] [Abstract][Full Text] [Related]
36. Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation.
Lopez-Beltran A; Cheng L; Andersson L; Brausi M; de Matteis A; Montironi R; Sesterhenn I; van det Kwast KT; Mazerolles C
Virchows Arch; 2002 Jan; 440(1):3-11. PubMed ID: 11942574
[TBL] [Abstract][Full Text] [Related]
37. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
38. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ
Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958
[TBL] [Abstract][Full Text] [Related]
39. An approach to the diagnosis of flat intraepithelial lesions of the urinary bladder using the World Health Organization/ International Society of Urological Pathology consensus classification system.
Amin MB; McKenney JK
Adv Anat Pathol; 2002 Jul; 9(4):222-32. PubMed ID: 12072813
[TBL] [Abstract][Full Text] [Related]
40. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
Dyrskjøt L; Kruhøffer M; Thykjaer T; Marcussen N; Jensen JL; Møller K; Ørntoft TF
Cancer Res; 2004 Jun; 64(11):4040-8. PubMed ID: 15173019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
